Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Randomized Clinical Trials of Letrozole Administration During Luteal Phase in Patients Who Have the Risk of Ovarian Hyperstimulation Syndrome

NCT02686151 is registered in ClinicalTrials.gov with The Affiliated Hospital of Inner Mongolia Medical University as lead sponsor.

NCT NCT02686151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02686151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Randomized Clinical Trials of Letrozole Administration During Luteal Phase in Patients Who Have the Risk of Ovarian Hyperstimulation Syndrome
Lead sponsor
The Affiliated Hospital of Inner Mongolia Medical University
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2023
Completion date
December 31, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian hyperstimulation syndrome